Tag Archives: symptoms
21
Nov
Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Menopause
This educational roundtable convenes leaders in women’s health to discuss t...
21
Nov
Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Women with Breast Cancer Receiving Endocrine Therapy
This educational roundtable convenes leaders in women’s health to discuss t...
14
Nov
Managing Vasomotor Symptoms with NK3 Receptor Antagonism
This educational roundtable convenes leaders in women’s health to discuss t...
14
Nov
Dual NK3/NK1 Receptor Antagonism for Vasomotor Symptoms
This educational roundtable convenes leaders in women’s health to discuss t...
07
Nov
Unmet Needs in Managing Vasomotor Symptoms in Menopause
This educational roundtable convenes leaders in women’s health to discuss t...
07
Nov
NK Receptor Antagonism as Therapeutic Strategy for Vasomotor Symptoms
This educational roundtable convenes leaders in women’s health to discuss t...
31
Oct
Impact of Vasomotor Symptoms on Patient Quality of Life
This educational roundtable convenes leaders in women’s health to discuss t...
31
Oct
Pathophysiology of Vasomotor Symptoms in Menopause
This educational roundtable convenes leaders in women’s health to discuss t...
28
Oct
Special Report: Managing vasomotor symptoms in menopause
In the first episode of this 10-part Contemporary OB/GYN Special Report, Jo...
24
Oct
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
The FDA has approved elinzanetant 60 mg capsules (Lynkuet; Bayer) for the t...